Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02428712
Title A Study of PLX8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Plexxikon
Indications

Advanced Solid Tumor

thyroid gland carcinoma

melanoma

Therapies

PLX8394

Age Groups: adult | senior | child
Covered Countries USA

Additional content available in CKB BOOST